目标提前！药明康德TIDES业务前三季度营收同比增长121%，多肽产能已超10WL

Core Insights - WuXi AppTec (603259.SH/2359.HK) reported its Q3 financial results on October 26, 2025, highlighting significant growth in its TIDES business and advancements in production capacity [1] Financial Performance - The company achieved TIDES business revenue of 7.84 billion yuan in the first three quarters, representing a year-on-year increase of 121.1% [1] Production Capacity - WuXi AppTec has completed the construction of its Taiqing peptide production capacity ahead of schedule, with over 10 WL of solid-phase synthesis reaction vessels operational in Q3, one quarter earlier than previously anticipated [1]